BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huang ML, Shen GT, Li NL. Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment. World J Clin Cases 2022; 10(32): 11690-11701 [PMID: 36405275 DOI: 10.12998/wjcc.v10.i32.11690]
URL: https://www.wjgnet.com/2307-8960/full/v10/i32/11690.htm
Number Citing Articles
1
Bo Zhou, Jie Li, Shuai Wu, Haomiao Zhang, Yuanbo Luo, Jingxiang Chen, Geng Chen. USP39/SMC4 promotes hepatoma cell proliferation and 5-FU resistanceScientific Reports 2025; 15(1) doi: 10.1038/s41598-025-93029-x
2
Yujing Chen, Jingyi Zhang, Jinfeng Yang, Jiawei Zhao, Xiaotong Guo, Juzheng Zhang, Jinfeng Gan, Weijia Zhao, Siqi Chen, Xinwen Zhang, Yi Lin, Jiamin Jin. Exploring the cancerous nexus: the pivotal and diverse roles of USP39 in cancer developmentDiscover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02480-9
3
Wenbiao Xiao, Bingwen Lin, Ying Wang, Peng Huang, Jiandong Lin, Xiongjian Xiao. USP31 PROMOTES THE INFLAMMATORY RESPONSE OF HUMAN LUNG ORGANOIDS TO LIPOPOLYSACCHARIDE TREATMENTShock 2025; 63(1): 110 doi: 10.1097/SHK.0000000000002464
4
Ziqi Chen, Meijun Zhong, Yuhui Lin, Wei Zhang, Yinghong Zhu, Lin Chen, Ziyao Huang, Kaiyuan Luo, Zhifeng Lu, Zhaoqi Huang, Yi Yan. METTL7B-induced histone lactylation prevents heart failure by ameliorating cardiac remodellingJournal of Molecular and Cellular Cardiology 2025; 202: 64 doi: 10.1016/j.yjmcc.2025.03.006
5
Mohamad Bakkar, Sara Khalil, Komal Bhayekar, Narva Deshwar Kushwaha, Amirreza Samarbakhsh, Sadaf Dorandish, Holly Edwards, Q. Ping Dou, Yubin Ge, Navnath S. Gavande. Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future ProspectsBiomolecules 2025; 15(2): 240 doi: 10.3390/biom15020240
6
Xiaohan Wang, Sisi Wei, Wanzhao Li, Xiaojian Wei, Cong Zhang, Suli Dai, Ming Ma, Lianmei Zhao, Baoen Shan. P-Hydroxylcinnamaldehyde induces tumor-associated macrophage polarization toward the M1 type by regulating the proteome and inhibits ESCC in vivo and in vitroInternational Immunopharmacology 2023; 119: 110213 doi: 10.1016/j.intimp.2023.110213
7
Danielle Whitham, Pathea Bruno, Norman Haaker, Kathleen F. Arcaro, Brian T. Pentecost, Costel C. Darie. Deciphering a proteomic signature for the early detection of breast cancer from breast milk: the role of quantitative proteomicsExpert Review of Proteomics 2024; 21(1-3): 81 doi: 10.1080/14789450.2024.2320158
8
Suaad Syed, Muhammad Yasir Khan Painda, Dawood Ghafoor, Dongjin Gu, Feng Wang. Physiological roles and therapeutic implications of USP6Cell Death Discovery 2025; 11(1) doi: 10.1038/s41420-025-02466-0
9
Lili Kong, Xiaofeng Jin. Dysregulation of deubiquitination in breast cancerGene 2024; 902: 148175 doi: 10.1016/j.gene.2024.148175
10
Guangce Xia, Yulin Guo, Jiajia Zhang, Meng Han, Xiangchao Meng, Ji Lv. An Overview of the Deubiquitinase USP53: A Promising Diagnostic Marker and Therapeutic TargetCurrent Protein & Peptide Science 2024; 25(9): 708 doi: 10.2174/0113892037292440240518194922
11
Pisong Li, Xiaoyu Zhu, Hui Qu, Zhongbin Han, Xingyu Yao, Yuan Wei, Baijun Li, Hongshen Chen. Synergistic Effect of Ubiquitin-Specific Protease 14 and Poly(ADP-Ribose) Glycohydrolase Co-Inhibition in BRCA1-Mutant, Poly(ADP-Ribose) Polymerase Inhibitor-Resistant Triple-Negative Breast Cancer CellsOncoTargets and Therapy 2024; : 741 doi: 10.2147/OTT.S463217